ID   TGBC-47
AC   CVCL_H709
DR   Wikidata; Q54972232
RX   CelloPub=CLPUB00275;
RX   PubMed=14532968;
RX   PubMed=15645130;
RX   PubMed=35640676;
CC   Population: Japanese.
CC   Doubling time: 38 +- 0.3 hours (PubMed=15645130).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4436; Cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 16
//
RX   CelloPub=CLPUB00275;
RA   Zach S., Birgin E., Ruckert F.;
RT   "Primary cholangiocellular carcinoma cell lines.";
RL   J. Stem Cell Res. Transplant. 2:1013-1013(2015).
//
RX   PubMed=14532968; DOI=10.3892/ijo.23.5.1293;
RA   Emura F., Kamma H., Ghosh M., Koike N., Kawamoto T., Saijo K.,
RA   Ohno T., Ohkohchi N., Todoroki T.;
RT   "Establishment and characterization of novel xenograft models of human
RT   biliary tract carcinomas.";
RL   Int. J. Oncol. 23:1293-1300(2003).
//
RX   PubMed=15645130; DOI=10.3892/ijo.26.2.449;
RA   Ghosh M., Koike N., Tsunoda S.-i., Hirano T., Kaul S., Kashiwagi H.,
RA   Kawamoto T., Ohkohchi N., Saijo K., Ohno T., Miwa M., Todoroki T.;
RT   "Characterization and genetic analysis in the newly established human
RT   bile duct cancer cell lines.";
RL   Int. J. Oncol. 26:449-456(2005).
//
RX   PubMed=35640676; DOI=10.1016/j.ajpath.2022.05.007; PMCID=PMC9472155;
RA   Isidan A., Yenigun A., Soma D., Aksu E., Lopez K., Park Y.,
RA   Cross-Najafi A., Li P., Kundu D., House M.G., Chakraborty S.,
RA   Glaser S., Kennedy L., Francis H., Zhang W.-J., Alpini G.D., Ekser B.;
RT   "Development and characterization of human primary cholangiocarcinoma
RT   cell lines.";
RL   Am. J. Pathol. 192:1200-1217(2022).
//